Case Report
Accepted on 18 Nov 2024
Case report: Effective Combination Therapy with Afatinib and Anlotinib in Lung Adenocarcinoma with Uncommon EGFR L858M/L861R Mutations
in Pharmacology of Anti-Cancer Drugs
Case Report
Accepted on 18 Nov 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Nov 2024
in Ethnopharmacology
Original Research
Published on 18 Nov 2024
in Pharmacology of Infectious Diseases
Original Research
Published on 18 Nov 2024
in Ethnopharmacology
Systematic Review
Published on 18 Nov 2024
in Experimental Pharmacology and Drug Discovery
Methods
Published on 18 Nov 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Nov 2024
in Pharmacogenetics and Pharmacogenomics
Correction
Published on 18 Nov 2024
in Ethnopharmacology
Original Research
Published on 18 Nov 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Nov 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 18 Nov 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 18 Nov 2024
in Ethnopharmacology
Original Research
Published on 18 Nov 2024
in Ethnopharmacology
Original Research
Published on 18 Nov 2024
in Pharmacology of Ion Channels and Channelopathies
Review
Published on 18 Nov 2024
in Cardiovascular and Smooth Muscle Pharmacology
Clinical Trial
Accepted on 15 Nov 2024
in Translational Pharmacology